SIU 2017 Prostate Cancer - Results from #20

Viewing 21-40 of 56 articles

SIU 2017: The Utility of Subsequent Prostate Biopsies for the Active Surveillance of Prostate Cancer when Genomics and MRI Are Negative

SIU 2017: Routine Use of Adjuvant Radiation After Radical Prostatectomy for Positive Surgical Margin: Not for All!

SIU 2017:Use of Radiation for Positive Surgical Margins in Prostate Cancer – argument for adjuvant radiotherapy

SIU 2017: Prostate-Specific Membrane Antigen-Radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer

SIU 2017: Oligometastatic Bone Disease in Prostate Cancer Patients Treated on the TROG 03.04 RADAR Trial

SIU 2017: Artificial Intelligence (AI) Can More Efficiently Predict Prostate Cancer Compared with PSADT and PSAD

SIU 2017: Management of Prostate Cancer in Men more than 80 Years of Age: Under or Over Treatment?

SIU 2017: Different Incidence of Prostate Cancer According to Metabolic Health Status: A Nationwide Cohort Study

SIU 2017: ProtecT, PIVOT and SPCG-4: Placing New Evidence into Context

SIU 2017: Evidence-Based Outcomes in Oncology: Implications for Patient Care

SIU 2017: ProtecT in 2017: What Have We Learnt?

SIU 2017: MRI As a Triage Test in Prostate Cancer Diagnostic Algorithm in Biopsy - Naïve Men: A Prospective Study

SIU 2017: Economic Effectiveness of Urinary PCA3 Test in Cases of Serum PSA Level 4-10 Ng/Ml

SIU 2017: Atypical Small Acinar Proliferation: Progression to Clinically Significant Prostate Cancer?

SIU 2017: Biojet – Real Time TRUS/MRI Fusion Biopsy of The Prostate: Value of Combining Targeted and Systematic Biopsies

SIU 2017: Transperineal Template-Guided Mapping Biopsy and Multiparametric MRI for Detection of Clinically Significant Prostate Cancer in Patients after initial Negative Trans-rectal Ultrasound-Guided Biopsy

SIU 2017: Combined Clinical Parameters and Multiparametric MRI for Advanced Risk Modeling of Prostate Cancer - Patient-Tailored Risk Stratification Can Reduce Unnecessary Biopsies

SIU 2017: Correlation of mpMRI Contours with 3-Dimensional 5mm Transperineal Prostate Mapping Biopsy within the PROMIS Trial Pilot: What Margins Are Required?

SIU 2017: Outcomes of Cognitive MRI Targeted TRUS Biopsy of Prostate

SIU 2017: Correlation between Multiparametric MRI PIRADS Scores and Prostate Carcinoma Grade Grouping on Transperineal Template +/- Targeted Biopsy

1
2
3